Skip to main content
. 2015 Nov 18;2015:457167. doi: 10.1155/2015/457167

Figure 1.

Figure 1

Serum Gal-9 levels in the four groups. (a) Compared with the NCA group, patients with CAD had significantly lower levels of Gal-9 (Figure 1(a)). (b) Serum Gal-9 levels were significantly lower in the STEMI and NSTEACS groups than those in the SAP group or the NCA group (Figure 1(b)). p < 0.05; ∗∗ p < 0.01.